Skip to main content

Emergence Agitation

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
AcetaminophenPhase 41 trial
Active Trials
NCT01737593Terminated108Est. Apr 2014
Humanwell Pharmaceutical
1 program
Rematazolam BesylatePHASE_41 trial
Active Trials
NCT05624424Unknown1,317Est. Oct 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Humanwell PharmaceuticalRematazolam Besylate
Angeles TherapeuticsAcetaminophen

Clinical Trials (2)

Total enrollment: 1,425 patients across 2 trials

NCT05624424Humanwell PharmaceuticalRematazolam Besylate

Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

Start: Nov 2022Est. completion: Oct 20231,317 patients
Phase 4Unknown
NCT01737593Angeles TherapeuticsAcetaminophen

Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?

Start: Nov 2012Est. completion: Apr 2014108 patients
Phase 4Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.